Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to find out whether the bioavailability of PT Dexa Medica's
formulation of 4 mg perindopril tert-butylamine tablets was equivalent to that of the
innovator's product (Prexum® 4 mg, Servier).